Indeed, Chamuleau et al. confirmed the anti-apoptotic function of decoy TRAIL-R3 in vitro by treating leukaemic cell lines and fresh primary AML samples with recombinant soluble TRAIL. The gene discussed is TNFSF10; the disease is acute myeloid leukemia.